Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New G protein-coupled receptor 39 agonists patented by Daiichi Sankyo

July 23, 2018

Toray cleared to begin phase I study of TRK-250 in patients with idiopathic pulmonary fibrosis

July 20, 2018

Blade Therapeutics initiates phase I study of BLD-2660

July 18, 2018

Nanjing Carephar Shenghui Pharmaceutical Co. divulges RORgammaT antagonists

July 17, 2018

Specific redox enzyme helps reverse fibrosis

July 17, 2018

GlaxoSmithKline, Astex Therapeutics describe NRF2 activators

July 13, 2018

Galapagos, AbbVie discover CFTR modulators

July 12, 2018

New NFE2L2 activators identified at GlaxoSmithKline

July 11, 2018

Bellus Health initiates phase I study of BLU-5937 for the treatment of chronic cough

July 10, 2018

Galapagos outlines phase II trial of GLPG-1205 in IPF

July 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...